The National Technical Advisory Group on Immunization (NTAGI) may decide on February 5 whether to use the new vaccine.
The government may introduce new vaccines – Corbevax and Covocax – for vaccination. Only emergency use will be allowed at this time. In fact, a new phase of vaccination is going to start in the country. It will vaccinate children between the ages of 12 and 14. The episode is expected to begin in March.
The National Technical Advisory Group on Immunization (NTAGI) may decide on February 5 whether to use the new vaccine. NTGI chief NK Aurora said that after vaccinating 15 to 18 year olds, now the campaign to vaccinate 12 to 14 year olds could start from March.
Kovacin from India Biotech is being given to children aged 15 to 18 years. However, a source said that the decision to vaccinate minors would depend on scientific data and the epidemic situation. The government launched a vaccination campaign in the country last year to protect people from the corona virus. After vaccinating more than 80 percent of the elderly, the focus is now on vaccinating children.
NTGI officials told Moneycontrol that the Serum Institute and the Biological Institute have been asked to present their data at a meeting on February 5. Produced by Kovavax Serum Institute, Pune. This is the American version of Novavax. Hyderabad-based Biologicals manufactures e Corvevax. Clinical trials of two vaccines in children are underway.
VK Paul, a member of the Policy Commission (Health) and head of the Covid Task Force, said the vaccination campaign could not be expanded immediately. However, it remains under consideration.
Read more: JNU Vice Chancellor M Jagdesh Kumar has been appointed as the new Chairman of UGC, Ministry of Education has announced.